在被诊断患有耐火性的葡萄牙患者中对Perampanel的人口药动力学分析
Rui Silva1,2, Helena Colom3,4, Joana Bicker1,2
1Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Pharmaceutics
|June 28, 2023
概括
这项研究开发了一个人群的药理动力学模型为perampanel,一种抗药物,以优化剂量对耐火性. 该模型考虑了诸如酶诱导抗药物和体重指数等因素.
科学领域:
- 药理动力学 药理动力学
- 的治疗方法 治疗
- 药物开发 药物开发
背景情况:
- 佩拉曼奈尔为治疗耐火性提供了一种新的机制.
- 优化抗药物 (AED) 剂量对于患者的治疗结果至关重要.
- 人口药理动力学 (PopPK) 建模有助于个性化剂量策略.
研究的目的:
- 开发一个PopPK模型用于perampanel在耐火性的成年患者.
- 为了确定影响佩拉曼奈尔药理动学的关键共变量.
- 为初始佩拉曼尼尔剂量优化提供基础.
主要方法:
- 分析了来自44名成年患者的72个帕拉曼尼尔血度.
- 使用非线性混合效应建模 (NONMEM) 进行PopPK分析.
- 采用了具有第一阶段淘汰的单间模型,并结合了共变量.
主要成果:
- 一个带有第一阶排泄的单间模型最好地描述了perampanel的药理动力学.
- 诱导酶的AED和体重指数分别是清除和分布量的重要共变量.
- 最终的模型显示了可接受的预测性能.
结论:
- 成功开发了一种可靠的PopPK模型,用于治疗耐火性的perampanel.
- 这种模型是第一个用于现实世界耐火性患者的成年患者.
- 开发的模型可以告知初始的perampanel剂量,以提高治疗疗效.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
211
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
211
Antiepileptic Drugs: Potassium Channel Activators
217
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
217
Analysis of Population Pharmacokinetic Data
301
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
301
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
136
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
136
Depolarizing Blockers: Pharmocokinetics
353
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
353
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
97
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
97


